Literature DB >> 21790965

Who has advanced heart failure?: definition and epidemiology.

Omar F Abouezzeddine1, Margaret M Redfield.   

Abstract

Summarizing current guidelines and advanced heart failure (AHF) clinical trials/registries, this review focuses on the current definition of AHF and emphasizes the secular trends in this definition over the last two decades. Further, clinical, imaging, hemodynamic, functional capacity and biomarker parameters that may aid clinicians to better recognize patients with AHF are reviewed. Finally, we review the limited data concerning the epidemiology of AHF which to date has been poorly characterized.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh：

Year:  2011        PMID： 21790965      PMCID： PMC3857759          DOI： 10.1111/j.1751-7133.2011.00246.x

Source DB:  PubMed          Journal:  Congest Heart Fail        ISSN： 1527-5299


  83 in total

1.  Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST).

Authors:  Paul A Grayburn; Christopher P Appleton; Anthony N DeMaria; Barry Greenberg; Brian Lowes; Jae Oh; Jonathan F Plehn; Peter Rahko; Martin St John Sutton; Eric J Eichhorn
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

2.  Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidémiologie de l'Insuffisance Cardiaque Avancée en Lorraine.

Authors:  F Zannad; S Briancon; Y Juilliere; P M Mertes; J P Villemot; F Alla; J M Virion
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

3.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

Authors:  B Pitt; F Zannad; W J Remme; R Cody; A Castaigne; A Perez; J Palensky; J Wittes
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

4.  Heart failure survival score continues to predict clinical outcomes in patients with heart failure receiving beta-blockers.

Authors:  Todd M Koelling; Susan Joseph; Keith D Aaronson
Journal:  J Heart Lung Transplant       Date:  2004-12       Impact factor: 10.247

5.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors:  R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

6.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.

Authors: 
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

7.  Comparison of survival by allocation to medical therapy, surgery, or heart transplantation for ischemic advanced heart failure.

Authors:  Eric Lim; Ziad Ali; Ayyaz Ali; Reza Motalleb-Zadeh; Christopher Jackson; Seok Ling Ong; James Halstead; Linda Sharples; Jayan Parameshwar; John Wallwork; Stephen R Large
Journal:  J Heart Lung Transplant       Date:  2005-08       Impact factor: 10.247

8.  Validation of peak exercise oxygen consumption and the Heart Failure Survival Score for serial risk stratification in advanced heart failure.

Authors:  Lars H Lund; Keith D Aaronson; Donna M Mancini
Journal:  Am J Cardiol       Date:  2005-03-15       Impact factor: 2.778

9.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

10.  Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure.

Authors:  G T Karatasakis; L A Karagounis; P A Kalyvas; A Manginas; G D Athanassopoulos; S A Aggelakas; D V Cokkinos
Journal:  Am J Cardiol       Date:  1998-08-01       Impact factor: 2.778
View more
  14 in total

1.  A longitudinal comparison of health-related quality of life in rural and urban recipients of left ventricular assist devices.

Authors:  Windy W Alonso; Kenneth M Faulkner; Bunny J Pozehl; Judith E Hupcey; Lisa A Kitko; Christopher S Lee
Journal:  Res Nurs Health       Date:  2020-07-06       Impact factor: 2.228

2.  Therapeutic options in advanced heart failure.

Authors:  Tarek Bekfani; Florian Westphal; P Christian Schulze
Journal:  Clin Res Cardiol       Date:  2018-07-09       Impact factor: 5.460

3.  Variation in practice patterns and outcomes across United Network for Organ Sharing allocation regions.

Authors:  Dushyanth Srinivasan; Benjamin Vaccaro; Pooja Rao; Rohit Ghosh; Prashant Warier; Tariq Ahmad; Nihar Desai
Journal:  Clin Cardiol       Date:  2018-01-22       Impact factor: 2.882

4.  Advanced Heart Failure Epidemiology and Outcomes: A Population-Based Study.

Authors:  Shannon M Dunlay; Véronique L Roger; Jill M Killian; Susan A Weston; Philip J Schulte; Anna V Subramaniam; Saul B Blecker; Margaret M Redfield
Journal:  JACC Heart Fail       Date:  2021-08-11       Impact factor: 12.544

5.  Patterns and predictors of dyspnoea following left ventricular assist device implantation.

Authors:  Kenneth M Faulkner; Corrine Y Jurgens; Quin E Denfeld; Christopher V Chien; Jessica Harman Thompson; Jill M Gelow; Kathleen L Grady; Christopher S Lee
Journal:  Eur J Cardiovasc Nurs       Date:  2022-10-14       Impact factor: 3.593

Review 6.  Long-term management of end-stage heart failure.

Authors:  Marlena V Habal; A Reshad Garan
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2017-07-18

7.  From statistical significance to clinical relevance: A simple algorithm to integrate brain natriuretic peptide and the Seattle Heart Failure Model for risk stratification in heart failure.

Authors:  Omar F AbouEzzeddine; Benjamin French; Sultan A Mirzoyev; Allan S Jaffe; Wayne C Levy; James C Fang; Nancy K Sweitzer; Thomas P Cappola; Margaret M Redfield
Journal:  J Heart Lung Transplant       Date:  2016-01-15       Impact factor: 10.247

8.  Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.

Authors:  Marat Fudim; Fatima Ali-Ahmed; Craig S Parzynski; Andrew P Ambrosy; Daniel J Friedman; Sean D Pokorney; Jeptha P Curtis; Gregg C Fonarow; Frederick A Masoudi; Adrian F Hernandez; Sana M Al-Khatib
Journal:  JAMA Cardiol       Date:  2020-06-01       Impact factor: 14.676

9.  Is ambulatory blood pressure measurement a new indicator for survival among advanced heart failure cases.

Authors:  Kotti K; Rajeev Bagarhatta; Monicka Rathore; Prachi Bagarhatta
Journal:  Indian Heart J       Date:  2017-09-06

10.  Cost-Effectiveness of a Small Intrapericardial Centrifugal Left Ventricular Assist Device.

Authors:  Scott C Silvestry; Claudius Mahr; Mark S Slaughter; Wayne C Levy; Richard K Cheng; Damian M May; Eleni Ismyrloglou; Stelios I Tsintzos; Edward Tuttle; Keziah Cook; Erica Birk; Aparna Gomes; Sophia Graham; William G Cotts
Journal:  ASAIO J       Date:  2020-08       Impact factor: 2.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.